跳至主要内容
临床试验/NCT05977985
NCT05977985尚未招募4 期

The Effects of Rotator Interval Hydro-dissection in Primary Adhesive Capsulitis. A Two-arm Double-blind Randomised Controlled Trial

University of Malaya0 个研究点目标入组 60 人开始时间: 2023年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
尚未招募
入组人数
60
主要终点
Shoulder pain

研究概览

简要总结

Adhesive capsulitis (AC) is a significant cause of chronic shoulder pain and disability. Non-surgical option consisting of intraarticular corticosteroid (IA CS) injection with structured physiotherapy (PT) is the current standard of care. More recent randomized controlled trials have found that rotator interval (RI) hydro-dissection approach leads to better improvement in pain as compared to IA approach. Despite being non-inferior to surgical management, long-term outcome studies of patients treated with IA CS injection and PT have shown that patients only achieve satisfactory outcomes in 72.3% of patients after a mean symptom duration of 41.8 months. Furthermore, CS injections are associated with significant systemic and local adverse effects such as Cushing syndrome, osteopenia/ osteoporosis, infection, and hyperglycemia. In recent years, dextrose injection has emerged as an effective alternative to CS-based injections to treat chronic painful musculoskeletal conditions such as chronic low back pain, peripheral nerve entrapment and lateral epicondylitis.

The investigators aim to study the effects of RI hydro-dissection with dextrose 5% (D5%) on pain relief, shoulder ROM and shoulder function in patients with primary AC.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
35 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with primary adhesive capsulitis
  • aged 35 to 65 years of age
  • duration of symptoms in between 3 to 18 months
  • limitation in flexion, abduction, and external rotation greater than 30 degrees compared to normal
  • limitation in internal rotation with hand to back shoulder test below L4

排除标准

  • diagnosis of connective tissue disease or inflammatory arthritis
  • history of surgery to the affected shoulder
  • history of shoulder dislocation/ fracture
  • neurological weakness of the affected upper limb
  • ultrasound findings of rotator cuff or LHBT tendinopathy
  • plain radiographs showing significant glenohumeral joint osteoarthritis (Kallgren-Lawrence grade 3 or 4)
  • other sources of chronic pain
  • bilateral adhesive capsulitis
  • history of pain intervention to the shoulder joint in the past 3 months
  • allergic reaction to local anesthetic agent

研究组 & 干预措施

Dextrose 5%

Experimental

Rotator interval hydro-dissection with dextrose 5% solution

干预措施: Rotator interval hydro-dissection with dextrose 5% (Drug)

Corticosteroid

Active Comparator

Rotator interval hydro-dissection with corticosteroid solution

干预措施: Rotator interval hydro-dissection with corticosteroid solution (Drug)

结局指标

主要结局

Shoulder pain

时间窗: 1 week, 4 weeks and 12 weeks post injection

Shoulder pain based on Shoulder Pain and Disability Index (SPADI) pain scale. The SPADI pain scale ranges from 0 to 50, with higher score indicating greater level of pain.

次要结局

  • Shoulder range of motion(4 weeks and 12 weeks post injection)
  • Shoulder function(4 weeks and 12 weeks post injection)

研究者

申办方类型
Other
责任方
Sponsor

相似试验